Introduction
Primary vitreoretinal lymphoma (PVRL) is a rare intraocular malignancy that is characterized by malignant lymphoid cells infiltrating the eye. PVRL is a subset of primary CNS lymphoma (PCNSL) and commonly masquerades as an intermediate or posterior uveitis [1, 2] . Delay in definitive diagnosis is common and leads to high morbidity [3] . Here, we present a unique case of PVRL diagnosed following enucleation. The patient was subsequently diagnosed with involvement in the fellow eye and CNS relapse. This case report received Emory University IRB exempt status. fig. 1 a) .
The patient had developed a blind painful eye secondary to unknown process, and we performed enucleation for both therapeutic and diagnostic purposes.
Pathologic Findings
External examination of the enucleated eye showed a hazy cornea with keratic precipitates. On gross section, there was cataract formation, blood strands within the retina, a detached necrotic retina and a subretinal white lesion ( fig. 1 b) . Histologic examination showed a mass of lymphocytes located between the retinal pigment epithelium and Bruch's membrane ( fig. 2 a) . These lymphocytes had large nuclei with prominent nucleoli and scanty cytoplasm ( fig. 2 b) . The large, neoplastic lymphocytes stained with CD20, indicating a large B-cell lymphoma ( fig. 3 a) . The small choroidal lymphocytes stained positively with CD3 indicating a population of reactive T lymphocytes ( fig. 3 b) . Collectively, histopathology of the enucleated left eye confirmed a diagnosis of large B-cell lymphoma (PVRL).
Discussion
The case presented herein represents an atypical presentation of rapidly progressive and fulminant PVRL diagnosed by enucleation. PVRL represents a subset of PCNSL and is defined as malignant lymphoid cells infiltrating the retina, vitreous and optic nerve [4] . PVRL is a rare ocular malignancy and the exact incidence is unknown. Better data exists for PCNSL with an estimated 1,900 reported cases within the United States in 2007. Intraocular involvement occurs in approximately 20% of cases and we can therefore estimate there are approximately 300-380 new cases of PVRL a year [1, 4, 5] . There is no racial predilection and PVRL more commonly affects men than women.
PVRL is a masquerade syndrome that mimics intermediate or posterior uveitis and usually affects the elderly (age >60 years). Most patients present with complaints of blurred vision and floaters, and ocular findings typically include a severe vitritis with subretinal infiltrates and RPE deposits [1] . Once infectious and inflammatory etiologies are ruled out, these patients commonly receive topical and systemic steroids. Initially, the inflammation and visual symptoms may respond, but the disease progresses, leading to worsening inflammation that is refractory to steroids.
There is a wide differential that must be considered, as PVRL can masquerade as infectious, inflammatory or neoplastic ocular disease [1] . Early diagnosis is critical, as delay can lead to increased morbidity. Once PVRL is suspected, patients should undergo systemic evaluation with neuroimaging and lumbar puncture due to the high incidence of concomitant CNS involvement. If negative, further diagnostic work-up must be pursued [5, 6] .
Histopathologic identification of malignant lymphoid cells is the gold standard for diagnosis [5] . Tissue can be obtained through various processes including aqueous sampling, vitreous tap, diagnostic vitrectomy, chorioretinal biopsy, and rarely as in our case diagnostic enucleation. Unfortunately, negative results are common, as lymphoma cells undergo rapid degradation following procurement [4] . Additionally, many patients receive preoperative steroid treatment and this contributes to decreased cell recovery. Therefore, it is important to work closely with an experienced pathologist who can perform cytology testing and immunohistochemistry.
This case is unusual due to the method of diagnosis, atypical presentation and fulminant course. AlQahtani et al. [7] reported other atypical presentations of PVRL that share some characteristics. Our patient seems to share these similar characteristics, including a younger age, female gender, presence of anterior chamber inflammation, and a mild vitritis. Our patient and one of the patients reported by AlQahtani et al. both had a rapidly progressive clinical course at the end resulting in no light perception vision [7] .
Initial systemic work-up after enucleation was negative, including neuroimaging and lumbar puncture. The fellow eye continued to have low-grade vitreous inflammation and decreased vision. There were no discrete masses or lesions. Therefore, a diagnostic vitrectomy was performed and revealed the presence of malignant lymphoid cells in the vitreous sample. The patient underwent local therapy with intravitreal methotrexate, and vision returned to 20/20. Concurrently, the patient was seen by neuro-oncology and undergoing surveillance neuroimaging. In March 2015, repeat MRI showed lesions within the CNS consistent with PCNSL. She was started on systemic high-dose methotrexate, temozolomide and rituximab.
Conclusion
PVRL often masquerades as intraocular inflammation or uveitis. A delay in diagnosis can lead to significant morbidity, thus diagnostic enucleation of a blind painful eye of unknown etiology should be considered.
